BLU-701 tumour suppression and intracranial activity as a single agent and in combination with BLU-945 in models of non-small cell lung cancer (NSCLC) driven by EGFR mutations. (March 2022) - Tavera, Luz; Zhang, Zhuo; Wardwell, Scott; Job, Ebby; McGinn, Katie; Chen, Maxine; Iliou, Maria; Albayya, Faris; Campbell, John; Eno, Meredith; Fernando, Dilinie; Dineen, Tom; et al.